Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
Published Date: 08 Mar 2023
Plant-based vegetarian and vegan diets may have the lowest carbon footprint in the United States, but new data analysis shows fish-based pescatarian diets are the best.
Read Full NewsA nurse practitioner at the Rocky Mountain MS Clinic discussed emerging therapeutics, evolving management strategies, and unmet needs in multiple sclerosis, specifically in women’s health.
The FDA has granted priority review to Takeda’s new drug application for oveporexton, an orexin receptor 2-selective agonist, for narcolepsy type 1, with a PDUFA date in the third quarter of 2026.
Paul Nghiem highlights several key takeaways from his talk on cutaneous oncology, touching on various advances in skin cancer management.
REZOLVE-AD: Rezpegaldesleukin Improves Symptoms of Atopic Dermatitis
1.
Kate Middleton Gives Cancer Update
2.
Study Supports Lactated Ringer Solution for Fluid Resuscitation in SCD
3.
New opportunities for screening and treatment have been created by the identification of the genetic drivers of esophageal cancer.
4.
Hair Growth After Cancer; 'Global' Early-Onset CRC; Retifanlimab Boosts OS in NSCLC
5.
FDA-approved FGFR inhibitors show promise against rare and aggressive pediatric brain tumor
1.
The Immunotherapeutic and Targeted Revolution in Melanoma Management – A 2025 Perspective
2.
Innovative Bioengineering Approaches for Erectile Function Recovery After Radical Prostatectomy
3.
Hepatocellular Carcinoma: Emerging Trends and Innovations in Diagnosis and Management
4.
The Risk Factors of Venous Thromboembolism and How to Lower Your Chances
5.
Uncovering the Mysteries of Breast Cancer: The Journey to a Cure
1.
International Lung Cancer Congress®
2.
Future NRG Oncology Meeting
3.
Genito-Urinary Oncology Summit 2026
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Navigating the Complexities of Ph Negative ALL - Part VII
2.
Rates of CR/CRi and MRD Negativity in Iontuzumab-Treated Patients
3.
Experts' Opinion on the Goal of Treatment of Patients with Relapsed Adult B-cell ALL
4.
Current Scenario of Cancer- Final Discussion on the Importance of Genomic Testing & Advancement in Diagnosis and Treatment
5.
Virtual Case Study on Elephantiasis of Lower Limb- An Initiative by Hidoc Dr.
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Join to enhance your clinical skills and gain specialized in-depth medical knowledge